IQVIA Holdings, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
IQVIA Holdings, Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA helps speed up drug development, ensure product quality and safety, improve commercial effectiveness, get the right treatments to patients, improve access and delivery of healthcare, and ultimately drive better health outcomes through its Connected Intelligence™ approach.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
IQVIA Holdings, Inc. is a net-positive Humankind Value company, with much of its positive value coming from Healthcare R&D ($86.2 B), Pharmaceuticals ($42.7 B), and Economic Value ($9.2 B). Its positive value from Healthcare R&D and Pharmaceuticals is linked to an estimated 2,500,000 additional years lived by people worldwide. Downsides for this company are associated with its Biofuel Production (-$1.1 B) and Greenhouse Gas (-$951.5 M) impacts. Healthcare R&D, Pharmaceuticals, Economic Value, Biofuel Production, and Greenhouse Gases are largely consequences of the actions of supply chain partners. For this firm, supply chain partners increase an already positive Humankind Value.